Table 1.
Summary of participants’ profiles.
| Participants (n = 128) | |
|---|---|
| Profile of participants | |
| Sex, No. (%) | Male: 37 (28.9), Female: 91 (71.1) |
| Category of age (years), No. (%) | ≤24, 12 (9.4), |
| 25–34, 52 (40.6), | |
| 35–44, 27 (21.1), | |
| 45–54, 20 (15.6), | |
| 55–64, 13 (10.2), | |
| ≥65, 4 (3.1) | |
| Type of facility, No. (%) | Hospital: 117 (91.4), |
| Clinic: 11 (8.6) | |
| Location of facility, No. (%) | Endemic area: 99 (77.3), |
| Non-endemic area: 29 (22.7) | |
| Risk factors for COVID-19 in the participants, No. (%) | At least one risk factor: 63 (49.2), |
| none: 65 (50.8) | |
| Risk factors for COVID-19 in the participants’ cohabitants, No. (%) | At least one risk factor: 61 (47.7), |
| none: 67 (52.3) | |
| Presence of cohabitants who had to be separated from respondents due to this pandemic, No. (%) | 3 (2.3) |
| History of COVID-19 infection in the respondent, No. (%) | 1 (0.8) |
| Vaccination against COVID-19, No. (%) | Not planned: 30 (23.4), |
| Planned: 71 (55.5), | |
| 1st dose: 24 (18.8), | |
| 2nd dose: 3 (2.3) | |
| Factors related to work | |
| Duration per study, median [IQR] | 60 [40–60] min |
| Examination frequency in the last two weeks, median [IQR] | 20 [10–40 |
| Experience of unexpected tests in two weeks, No. (%) | 87 (68.0) |
| Experience of EEG with hyperventilation in two weeks, No. (%) | 47 (36.7) |
| Experience of EEG monitoring in two weeks, No. (%) | 60 (46.9) |
| Test for outpatient, inpatients, or both, No. (%) | Outpatient: 14 (10.9), |
| inpatient: 11 (8.6), | |
| both 103 (80.5) | |
| Examination for patients with COVID-19 or suspected of having COVID-19, No. (%) | 12 (9.4) |
| Infection prevention protocols, screening interviews/examinations, guidelines, or agreements regarding examination, No. (%) | 121 (94.5) |
| Counseling/consultation office to talk about mental stress related to the pandemic, No. (%) | 89 (69.5) |
| Availability of N95 mask, No. (%) | 35 (27.3) |
| Change in salary/bonus during the pandemic, No. (%) | Down: 17 (13.3), |
| No change: 54 (42.2), | |
| Up: 57 (44.5) | |
| Outcome measurements | |
| K-6 5, No. (%) | 45 (35.2) |
| TMDP 14, No. (%) | 45 (35.2) |
SD: standard deviation; IQR: interquartile range; TMDP: Tokyo Metropolitan Distress Scale for Pandemic; EEG: electroencephalography.